Survey asks seriously ill patients: ‘What’s worse than death?’

Bowel and bladder incontinence was described as equal to or worse than death by a majority of seriously ill patients participating in a survey published in JAMA.

Emily Rubin, MD, JD, a second year fellow in pulmonary and critical care medicine at the Hospital of the University of Pennsylvania, and her co-authors, surveyed 180 patients with conditions such as advanced cancer, congestive heart failure and severe obstructive or restrictive lung disease. They were asked to rate health states on a five-point scale of (5) worse than death, (4) neither better nor worse than death, (3) a little better than death, (2) somewhat better or (1) much better.

Several states were described by a majority of patients as either the same or worse than death: bowel and bladder incontinence (124, 68.9 percent), requiring a breathing tube to live (121, 67.2 percent) or requiring round-the-clock care (97, 53.9 percent).

On the other end of the spectrum, living in a wheelchair was described as much or somewhat better than death by more than 70 percent of participants.

“Hospitalized patients with serious and potentially life-limiting illnesses are at high risk for experiencing outcomes that many would consider to be worse than death,” Rubin and co-authors wrote. “Nonetheless, studies of interventions in the hospital and specifically the intensive care unit, as well as hospital quality measures, commonly ignore such preferences, assuming implicitly or explicitly that death is an outcome to be avoided no matter what the alternatives are. This assumption may create untoward incentives for clinicians or health care systems to provide care that results in states of severe functional debility that patients prefer to avoid, even if the alternative is death.”

There could be many explanations as to why seriously ill patients may receive life-prolonging care even once they’ve reached these feared states, Rubin said, including changing preferences or willingness to endure those states for the sake of family members. Some reasons, however, may be blamed on poor planning for end-of-life care by clinicians, such as being unaware of what the patient values or failing to discuss alternatives consistent with a patient’s priorities.

While the survey was limited to patients at a single hospital, Rubin said having a broad range of patients view certain health states as worse to or comparable to death should make researchers rethink their definition of patient-centered outcomes and perhaps inform new quality measures on avoiding those feared states. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.